Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Micro-X Limited (MX1.AX)
AUD0.03
+0.00 (+6.25%)
AU ASX Healthcare Medical - Specialties
Address
A14, 6 MAB Eastern Promenade 5042
Tonsley, SA, AU
Tonsley, SA, AU
CEO
Kingsley Campbell Hall
Website
micro-x.com
IPO
2015-12-21
ISIN AU000000MX15
Description
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; Argus, a wide-area scattered projection backscatter and miniaturized high-voltage generator; and space imaging solutions. The company operates in Australia, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD0.03
+0.00 (+6.25%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
603.8K
Beta
-0.62
Float Shares
727.84M
Free Float %
99.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.38% | -6.82% | -21.15% | -45.33% | -52.33% | -60.95% | -25.45% | -66.98% | -87.86% | -89.26% | -92.93% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.03
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-13.88
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%-14.3% Q4'25: +23.3% (vs Q4'23)
-
EPS growth Medical - Specialties: +10.1%-23.2% Q4'25: +33.1% (vs Q4'23)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-89.3% Q4'25: -30.2% (vs Q4'23)
-
EBIT margin Medical - Specialties: +12.6%-102.2% Q4'25: -61.0% (vs Q4'23)
-
ROIC Medical - Specialties: +6.6%-123.0% Q4'25: -423.3% (vs Q4'23)
-
Share dilution Medical - Specialties: 0.0%+15.8% Q4'25: +29.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-0.56× Q4'25: -0.23× (vs Q4'23)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
892.0K
est: 500.0K (+78.4%)
|
659.0K
est: 3.53M (-81.3%)
|
1.61M
est: 1.90M (-15.4%)
|
1.93M
est: 2.00M (-3.5%)
|
4.25M
est: 3.20M (+32.8%)
|
3.77M
est: 4.20M (-10.2%)
|
8.97M
est: 3.80M (+136.1%)
|
15.01M
est: 21.36M (-29.8%)
|
15.22M
est: 23.50M (-35.2%)
|
13.05M
est: 23.90M (-45.4%)
|
26.86M
26.86M – 26.86M
+12.4% YoY
|
28.90M
28.90M – 28.90M
+7.6% YoY
|
45.83M
45.83M – 45.83M
+58.6% YoY
|
| EBITDA |
-19.25M
est: -484.4K (-3,874.4%)
|
-19.30M
est: -94.46M (+79.6%)
|
-13.10M
est: -7.52M (-74.2%)
|
-11.44M
est: -1.94M (-490.4%)
|
-9.29M
est: -15.68M (+40.8%)
|
-13.61M
est: -59.39M (+77.1%)
|
-19.02M
est: -154.63M (+87.7%)
|
-15.54M
est: -276.83M (+94.4%)
|
-14.35M
est: -608.16M (+97.6%)
|
-11.76M
est: -1.34B (+99.1%)
|
-26.02M
-26.02M – -26.02M
+98.1% YoY
|
-28.00M
-28.00M – -28.00M
-7.6% YoY
|
-44.40M
-44.40M – -44.40M
-58.6% YoY
|
| EBIT |
-19.22M
est: -500.0K (-3,743.0%)
|
-19.34M
est: -55.05M (+64.9%)
|
-16.41M
est: -6.83M (-140.1%)
|
-12.18M
est: -2.00M (-509.2%)
|
-11.25M
est: -15.79M (+28.7%)
|
-15.94M
est: -50.08M (+68.2%)
|
-20.45M
est: -130.39M (+84.3%)
|
-17.13M
est: -233.44M (+92.7%)
|
-15.89M
est: -512.84M (+96.9%)
|
-13.33M
est: -1.13B (+98.8%)
|
-26.86M
-26.86M – -26.86M
+97.6% YoY
|
-28.90M
-28.90M – -28.90M
-7.6% YoY
|
-45.83M
-45.83M – -45.83M
-58.6% YoY
|
| Net Income |
-10.74M
est: -44.71M (+76.0%)
|
-12.92M
est: -74.76M (+82.7%)
|
-16.60M
est: -7.18M (-131.2%)
|
-9.83M
est: -30.83M (+68.1%)
|
-10.07M
est: -15.73M (+36.0%)
|
-14.73M
est: -54.74M (+73.1%)
|
-17.09M
est: -142.51M (+88.0%)
|
-10.75M
est: -255.14M (+95.8%)
|
-9.77M
est: -9.77M (+0.0%)
|
-13.90M
est: -6.70M (-107.4%)
|
-5.49M
-5.49M – -5.49M
+18.0% YoY
|
-1.22M
-1.22M – -1.22M
+77.8% YoY
|
4.88M
4.88M – 4.88M
+500.0% YoY
|
| SGA |
2.03M
est: 884.1K (+129.3%)
|
3.92M
est: 6.25M (-37.2%)
|
5.56M
est: 3.36M (+65.5%)
|
6.80M
est: 3.54M (+92.2%)
|
4.00M
est: 5.66M (-29.4%)
|
10.91M
est: 7.43M (+46.8%)
|
17.89M
est: 6.72M (+166.3%)
|
19.50M
est: 37.77M (-48.4%)
|
18.32M
est: 41.55M (-55.9%)
|
18.95M
est: 42.26M (-55.2%)
|
47.49M
47.49M – 47.49M
+12.4% YoY
|
51.10M
51.10M – 51.10M
+7.6% YoY
|
81.03M
81.03M – 81.03M
+58.6% YoY
|
| EPS |
-0.17
est: -0.07 (-132.1%)
|
-0.10
est: -0.10 (-5.0%)
|
-0.11
est: -0.05 (-113.5%)
|
-0.07
est: -0.07 (+10.7%)
|
-0.04
est: -0.05 (+8.5%)
|
-0.04
est: -0.27 (+86.2%)
|
-0.04
est: -0.03 (-7.0%)
|
-0.02
est: -0.02 (+4.8%)
|
-0.02
est: -0.02 (-9.9%)
|
-0.02
est: -0.01 (-75.4%)
|
-0.01
-0.01 – -0.01
+30.8% YoY
|
0.00
0.00 – 0.00
+77.8% YoY
|
0.01
0.01 – 0.01
+500.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-19.42M
OE per share TTM
-0.03
Owner's Yield
-70.77%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
73.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-1.7K
Shares Outstanding
729.19M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kingsley Hall | Chief Executive Officer | 401.4K | male |
| Anthony Skeats | Chief Operating Officer | 377.5K | male |
| Brian Gonzales | Chief Executive Officer of US & Chief Scientific Officer | 370.7K | — |
| Scott Bryant | Chief Sales Officer | — | male |
| Peter Dickman | Chief Financial Officer | — | male |
| Rebecca Puddy | Head of Corporate Communications | — | female |
| Richard Walter-Cumming Willson B.Acc FAICD FCPA | Company Secretary | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MX1.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
